Skip to main content
TipRanks
Go Ultimate75% OFF

Vibe Bioscience Ltd (VIBE) Stock Price & Analysis

9 Followers

VIBE Stock Chart & Stats

CA$0.63CA$0.00(0.00%)
At close: 4:00 PM EST
C$0.45C$0.5C$0.55C$0.6Sep 1Sep 14Sep 25Oct 13
Day’s Range
CAD 0.63 - CAD 0.63
52-Week Range
CAD 0.30 - CAD 0.65
Previous Close
CAD 0.63
Volume
N/A
Average Volume (3M)
175
Market Cap
CAD 680.21K
Enterprise Value
CAD 2.56M
Total Cash (Recent Filing)
CAD 835.52K
Total Debt (Recent Filing)
CAD 2.30M
Price to Earnings (P/E)
―
Beta
2.37
Next Earnings
Nov 26, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue And Operating Rebound

The latest period shows a meaningful operating recovery, with revenue growth accompanied by positive EBIT and EBITDA margins. If this improvement persists, it could strengthen internal funding capacity, support reinvestment, and improve the company’s ability to build more durable earnings power.

Positive Operating And Free Cash Flow

Positive operating and free cash flow indicate that the business is currently generating cash despite reporting a net loss. This provides greater flexibility to support operations and investment, although continued positive conversion will be important for establishing a sustainable financial foundation.

Steady Gross Margins

Relatively stable gross margins suggest the company has maintained its underlying economics while operations improved. Margin consistency can help make future revenue growth more valuable, provide a base for operating leverage, and reduce dependence on exceptionally favorable pricing or cost conditions.

Bears Say

Negative Shareholders’ Equity

Negative equity materially limits financial flexibility and indicates that the company’s accumulated financial position remains weak. It can increase dependence on external funding, raise dilution or refinancing risk, and restrict the resources available to absorb setbacks or finance growth.

Continuing Net Losses

The company has not yet converted its operational rebound into bottom-line profitability. Continued net losses can consume financial resources, weaken retained capital, and make the recent margin improvement less durable unless revenue growth and operating gains continue to outweigh remaining costs.

Cash-flow Consistency Risk

Although the latest period produced positive operating and free cash flow, the historical swings show that cash generation has not yet been demonstrated consistently. Future funding flexibility therefore remains sensitive to operating volatility and the company’s ability to sustain recent improvements.

VIBE FAQ

What was Vibe Bioscience Ltd’s price range in the past 12 months?
Vibe Bioscience Ltd lowest stock price was C$0.30 and its highest was C$0.65 in the past 12 months.
What is Vibe Bioscience Ltd’s market cap?
Vibe Bioscience Ltd’s market cap is C$680.21K.
When is Vibe Bioscience Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vibe Bioscience Ltd’s earnings last quarter?
Vibe Bioscience Ltd released its earnings results on Aug 31, 2026. The company reported -C$1.271 earnings per share for the quarter.
Is Vibe Bioscience Ltd overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Vibe Bioscience Ltd pay dividends?
Vibe Bioscience Ltd does not currently pay dividends.
What is Vibe Bioscience Ltd’s EPS estimate?
Vibe Bioscience Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vibe Bioscience Ltd have?
Vibe Bioscience Ltd has 1,079,699 shares outstanding.
What happened to Vibe Bioscience Ltd’s price movement after its last earnings report?
Vibe Bioscience Ltd reported an EPS of -C$1.271 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Vibe Bioscience Ltd?
Currently, no hedge funds are holding shares in TSE:VIBE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology